OnabotulinumtoxinA (Botox®): A Review of its Use in the Treatment of Urinary Incontinence in Patients with Multiple Sclerosis or Subcervical Spinal Cord Injury-Reference-Cited by-同舟云学术

OnabotulinumtoxinA (Botox®): A Review of its Use in the Treatment of Urinary Incontinence in Patients with Multiple Sclerosis or Subcervical Spinal Cord Injury

Published:2014-07-25 Issue:14 Volume:74 Page:1659-1672
ISSN:0012-6667
Container-title:Drugs
language:en
Short-container-title:Drugs

Author:

Sanford Mark

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

http://link.springer.com/content/pdf/10.1007/s40265-014-0271-z.pdf

Reference48 articles.

1. Benarroch EE. Neural control of the bladder: recent advances and neurologic implications. Neurology. 2010;75(20):1839–46.

2. Nicholas R, Young C, Friede T. Bladder symptoms in multiple sclerosis: a review of pathophysiology and management. Expert Opin Drug Saf. 2010;9(6):905–15.

3. Tubaro A, Puccini F, De Nunzio C, et al. The treatment of lower urinary tract symptoms in patients with multiple sclerosis: a systematic review. Curr Urol Rep. 2012;13:335–42.

4. Sahai A, Cortes E, Seth J, et al. Neurogenic detrusor overactivity in patients with spinal cord injury: evaluation and management. Curr Urol Rep. 2011;12(6):404–12.

5. Fowler CJ, Panicker JN, Drake M, et al. A UK consensus on the management of the bladder in multiple sclerosis. Postgrad Med. 2009;85:552–9.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Sustained Therapeutic Effects of Percutaneous Posterior Tibial Nerve Stimulation in the Treatment of Neurogenic Lower Urinary Tract Symptoms in Patients with Parkinson's Disease: 24-months Clinical and Urodynamic Results;Urology;2021-07

2. Efficacy and safety of mirabegron for the treatment of neurogenic detrusor overactivity resulting from traumatic spinal cord injury: A prospective study;Neurourology and Urodynamics;2021-01-07

3. Will repeated botulinum toxin A improve detrusor overactivity and bladder compliance in patients with chronic spinal cord injury?;Tzu Chi Medical Journal;2021

4. How long does the effect of botulinum toxin in neurogenic patients last? An analysis of the subset of “good responders”;LUTS: Lower Urinary Tract Symptoms;2019-12-19

5. Efficacy and safety of intradetrusor onabotulinumtoxinA injection for managing paediatric non-neurogenic overactive bladder: A prospective case-series study;Arab Journal of Urology;2019-04-03